These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19885986)

  • 1. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event?].
    Oreziak A; Przybylski A
    Kardiol Pol; 2009 Aug; 67(8):930-1. PubMed ID: 19885986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event? A case report].
    Krzyzanowski K; Michałkiewicz D; Wierzbowski R; Gniłka A; Ryczek R; Orski Z; Kubik L
    Kardiol Pol; 2009 Aug; 67(8):927-9. PubMed ID: 19784895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R; Shah AJ; Keebler M; Thakur RK
    Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism?
    Vollmann D; Lüthje L; Zabel M
    Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370
    [No Abstract]   [Full Text] [Related]  

  • 5. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 6. An unusual case of impossible communication between an ICD and programmer.
    Attanasio P; Wutzler A; Huemer M; Parwani AS; Boldt LH; Haverkamp W; Blaschke F
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):230. PubMed ID: 25257919
    [No Abstract]   [Full Text] [Related]  

  • 7. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?
    Gersh B
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):16-7. PubMed ID: 16265252
    [No Abstract]   [Full Text] [Related]  

  • 9. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent ventricular fibrillation during a febrile illness and hyperthermia in a patient with dilated cardiomyopathy and automatic implantable cardioverter defibrillator. An example of reversible electrical storm.
    D'Aloia A; Faggiano P; Brentana L; Boldini A; Curnis A; Bontempi L; Dei Cas L
    Int J Cardiol; 2005 Aug; 103(2):207-8. PubMed ID: 16080982
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic capabilities of devices for cardiac resynchronization therapy.
    Gardini A; Lupo P; Zanelli E; Bisetti S; Cappato R
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):186-9. PubMed ID: 19829134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device therapy: Defibrillators-a shocking therapy for cardiomyopathy?
    Cleland JG; Buga L
    Nat Rev Cardiol; 2010 Feb; 7(2):69-70. PubMed ID: 20104242
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy.
    Strohmer B; Schernthaner C; Pichler M
    Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment.
    Kanoupakis EM; Manios EG; Kallergis EM; Mavrakis HE; Goudis CA; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE
    J Am Coll Cardiol; 2010 Jun; 55(24):2753-9. PubMed ID: 20538169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator.
    Mickleborough LL
    Adv Card Surg; 1994; 5():209-30. PubMed ID: 8118593
    [No Abstract]   [Full Text] [Related]  

  • 17. Shocking truths about implantable cardioverter defibrillator monitoring zones.
    Mansour F; Thibault B; Dubuc M; Guerra PG; Macle L; Brugada R; Roy D; Talajic M; Khairy P
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1146-8. PubMed ID: 17725760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implantable cardiac defibrillator.
    Kamalvand K; Gill JS
    Br J Hosp Med; 1996 Jan 17-Feb 6; 55(1-2):37-41. PubMed ID: 8646390
    [No Abstract]   [Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.